These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression. Zhang L, He L, Zhang H, Chen Y. Cell Physiol Biochem; 2018; 47(4):1432-1441. PubMed ID: 29940575 [Abstract] [Full Text] [Related]
3. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells. Tanaka S, Hosokawa M, Yonezawa T, Hayashi W, Ueda K, Iwakawa S. Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925 [Abstract] [Full Text] [Related]
4. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou Y, Wang Y, Liu L, Zhang Y. Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904 [Abstract] [Full Text] [Related]
5. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. Wei J, Qi X, Zhan Q, Zhou D, Yan Q, Wang Y, Mo L, Wan Y, Xie D, Xie J, Yang S. Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225 [Abstract] [Full Text] [Related]
6. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity. Hua Y, Zhu Y, Zhang J, Zhu Z, Ning Z, Chen H, Liu L, Chen Z, Meng Z. Cell Physiol Biochem; 2018 Apr; 51(5):2148-2159. PubMed ID: 30522111 [Abstract] [Full Text] [Related]
7. miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer. Huang G, Chen X, Cai Y, Wang X, Xing C. Oncol Rep; 2017 Jan; 37(1):571-578. PubMed ID: 28004114 [Abstract] [Full Text] [Related]
8. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX. Hu J, Cai G, Xu Y, Cai S. Curr Mol Med; 2016 Jan; 16(1):70-82. PubMed ID: 26695693 [Abstract] [Full Text] [Related]
9. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. Ghanbarian M, Afgar A, Yadegarazari R, Najafi R, Teimoori-Toolabi L. Biomed Pharmacother; 2018 Dec; 108():1070-1080. PubMed ID: 30372807 [Abstract] [Full Text] [Related]
10. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X. Mol Oncol; 2014 Feb; 8(1):83-92. PubMed ID: 24145123 [Abstract] [Full Text] [Related]
11. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y, Mori M. Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955 [Abstract] [Full Text] [Related]
12. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Sun W, Li J, Zhou L, Han J, Liu R, Zhang H, Ning T, Gao Z, Liu B, Chen X, Ba Y. Theranostics; 2020 Sep; 10(5):1981-1996. PubMed ID: 32104496 [Abstract] [Full Text] [Related]
13. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway. Zhang Y, Liu X, Zhang J, Xu Y, Shao J, Hu Y, Shu P, Cheng H. Aging (Albany NY); 2020 Mar 25; 12(7):5640-5650. PubMed ID: 32209726 [Abstract] [Full Text] [Related]
14. Effects of Decitabine on Invasion and Exosomal Expression of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells. Tanaka S, Hosokawa M, Ueda K, Iwakawa S. Biol Pharm Bull; 2015 Mar 25; 38(9):1272-9. PubMed ID: 26179333 [Abstract] [Full Text] [Related]
15. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2). Qin Y, Chen X, Liu Z, Tian X, Huo Z. Med Sci Monit; 2018 Jul 16; 24():4944-4951. PubMed ID: 30011263 [Abstract] [Full Text] [Related]
16. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4. Azar MRMH, Aghazadeh H, Mohammed HN, Sara MRS, Hosseini A, Shomali N, Tamjidifar R, Tarzi S, Mansouri M, Sarand SP, Marofi F, Akbari M, Xu H, Shotorbani SS. Int Immunopharmacol; 2021 Mar 16; 92():107355. PubMed ID: 33429333 [Abstract] [Full Text] [Related]
17. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L. Mol Carcinog; 2017 Dec 16; 56(12):2669-2680. PubMed ID: 28767179 [Abstract] [Full Text] [Related]
18. MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer. Zhang Y, Geng L, Talmon G, Wang J. J Biol Chem; 2015 Mar 06; 290(10):6215-25. PubMed ID: 25616665 [Abstract] [Full Text] [Related]
19. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1. Liu H, Yin Y, Hu Y, Feng Y, Bian Z, Yao S, Li M, You Q, Huang Z. Pathol Res Pract; 2016 Jul 06; 212(7):643-9. PubMed ID: 27173050 [Abstract] [Full Text] [Related]
20. Methionine restriction enhances the chemotherapeutic sensitivity of colorectal cancer stem cells by miR-320d/c-Myc axis. Liu C, Wang JL, Wu DZ, Yuan YW, Xin L. Mol Cell Biochem; 2022 Jul 06; 477(7):2001-2013. PubMed ID: 35394639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]